Clinical Report: Advancing Neurological Rehabilitation via Regenerative Medicine

Overview

This editorial highlights the integration of regenerative medicine and neurorehabilitation to enhance recovery after central nervous system injuries. Key advances include targeting endogenous neural stem cells, non-coding RNAs, white matter plasticity, and neuromodulatory interventions such as vagus nerve stimulation.

Background

Functional recovery after central nervous system (CNS) injuries remains challenging due to limited intrinsic repair capacity. Regenerative neurorehabilitation combines molecular, cellular, and physical strategies to promote neurological repair. Spinal cord injury (SCI) is a major focus, with research exploring endogenous neural stem cells, molecular regulators, and activity-dependent mechanisms. Emerging therapies also extend to neuroimmune and neurodegenerative disorders, emphasizing personalized and multimodal approaches.

Data Highlights

A pilot randomized controlled trial demonstrated that vagus nerve stimulation paired with intensive upper limb rehabilitation improved motor outcomes in chronic cervical SCI patients. Genomic analyses identified shared biomarkers between SCI and sarcopenia, suggesting potential diagnostic and prognostic utility. Preclinical studies showed that 2′-fucosyllactose reduced amyloid pathology and neuroinflammation in Alzheimer's disease models, improving cognitive function.

Key Findings

• Endogenous neural stem cells proliferate post-injury but preferentially differentiate into astrocytes, limiting neuronal regeneration.
• Non-coding RNAs modulate inflammation, oxidative stress, and axonal remodeling, representing promising therapeutic targets.
• White matter repair via oligodendrocyte precursor cells can be enhanced by activity-dependent rehabilitation and physical activity.
• Vagus nerve stimulation combined with task-specific training shows potential to amplify neuroplasticity and improve motor recovery in SCI.
• Cellular therapies in neuromyelitis optica spectrum disorder may provide long-term immune stabilization beyond conventional treatments.
• Metabolic interventions like 2′-fucosyllactose exhibit neuroprotective effects in neurodegenerative disease models.

Clinical Implications

Integrating regenerative biology with rehabilitative strategies offers a promising pathway to enhance neurological recovery beyond compensation. Clinicians should consider multimodal approaches that combine pharmacological, cellular, and activity-based therapies tailored to individual patient profiles. Neuromodulatory techniques such as vagus nerve stimulation may augment rehabilitation outcomes in chronic CNS injury.

Conclusion

The convergence of molecular, cellular, and physical interventions in regenerative neurorehabilitation represents a critical advance toward genuine biological repair. Continued interdisciplinary collaboration is essential to translate these innovations into effective clinical therapies for neurological recovery.

References

1. Editorial on Transforming neurological recovery: the promise of regenerative neurorehabilitation